Zydus gets USFDA nod for Dexamethasone Tablets USP, 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg and Dexamethasone Tablets USP, 2 mg Read more
US FDA approves Casgevy, cell-based gene therapy to treat transfusion-dependent beta-thalassemia Read more